Propyzamide


CAS No. : 23950-58-5

(Synonyms: Kerb; RH 315)

23950-58-5
Price and Availability of CAS No. : 23950-58-5
Size Price Stock
1g $25 In-stock
5g $58 In-stock
10g $80 In-stock
50 g Get quote
100 g Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-B1883
M.Wt: 256.13
Formula: C12H11Cl2NO
Purity: >98 %
Solubility: DMSO : 200 mg/mL (ultrasonic)
Introduction of 23950-58-5 :

Propyzamide (Kerb) is an orally active inhibitor of β-tubulin and AHR signaling pathways. Propyzamide binds β-tubulin at the intradimer interface, disrupting microtubule assembly, leading to mitotic arrest and multipolar spindle formation. Propyzamide enhances C/EBPβ and NF-κB signaling, promoting colitogenic helper T cell differentiation and interleukin-17/interferon gamma-expressing colonic T cells. Propyzamide can be used in research on colitis, inflammatory bowel disease, and liver cancer[1][2][3][4][5][6]. In Vitro:Propyzamide (2-10 µM) boosts Th1/Th17 differentiation in mouse naive CD4+ T cells and human CD3+ T cells in an NF-κB-C/EBPβ-dependent manner[2].
Propyzamide (20 μM; 48-72 h) arrests Vigna radiata root meristem cells in prophase (83.41% at 48 h; 73.26% at 72 h) and disrupts spindle microtubules[5].
Propyzamide (100 μM; 6 days) inhibits Nicotiana tabacum cv. BY-2 cell division, reaching 53% inhibition in the conductivity assay[6].
Propyzamide (0.75 μM-0.1 M; 24 h) causes complete depolymerization of cortical and spindle microtubules and induces multipolar spindle formation in Nicotiana tabacum cv. BY-2 cells[6].
Propyzamide (2-10 µM) suppresses FICZ-induced AHR-target gene expression in human and mouse primary DCs and T cells[2].
Propyzamide (2-10 µM) enhances T cell activation and Th1/Th17 polarization in mouse and human DCs, dependent on C/EBPβ[2].
Propyzamide (2 µM) promotes C/EBPβ recruitment to Ifng, Il12rb1, and Rorc promoters in mouse T cells[2].
Propyzamide (2-10 µM) boosts NF-κB activation and pro-inflammatory cytokine expression in mouse and human DCs[2].
Propyzamide (50 μM; 24 h) activates xenobiotic metabolism and nuclear receptor signaling pathways in differentiated HepaRG cells, with predicted PXR, CAR, NRF2, and PP2A subunit induction[3].
Propyzamide (3.13-50 μM; 24 h) induces CYP2B6 and CYP3A4 expression in differentiated HepaRG cells from 6.25 μM, with 3.4- and 3.0-fold increases at 50 μM[3].
Propyzamide (3.13-50 μM; 24 h)-induced CYP1A2, CYP2B6, and CYP3A4 expression in differentiated HepaRG cells is suppressed by MC-LA or MC-LR at 0.6 μM, demonstrating functional antagonism[3].
Propyzamide (50 μM; 24 h) combined with MC-LR (0.6 μM) produces transcriptional profiles in differentiated HepaRG cells that largely resemble MC-LR alone while adding HCC- and inflammation-related DEGs[3].
Propyzamide (300-1,000 µM; overnight at 4 °C) competes with [3H]TCDD for binding to mouse and human AHR in cell-free assays[2].
Propyzamide (10 µM) inhibits FICZ-induced AHR activation in HEK293FT/DC2.4 AHR reporter cells[2].
Propyzamide (10 µM) activates VCAM1 and C/EBPβ-dependent pro-inflammatory promoters in reporter assays[2].
Propyzamide (3.13-50 μM; 24 h) alone is not cytotoxic in differentiated HepaRG cells up to 50 μM, whereas combined with 0.6 μM MCs it reduces viability to approximately 80% at 50 μM[3].
Propyzamide (50 μM; 24 h) weakly inhibits PP2A activity in differentiated HepaRG cells, with a relative activity of 0.84[3].
Propyzamide (50 µM; 48 h) disrupts β-tubulin immunolocalization in C. vulgaris spermatids, reducing signals at stages IV-VI and eliminating them from stages VII-X, with nuclear distortion at stages V, VII, and VIII[4].
Propyzamide (50 µM; 48 h) induces extensive ultrastructural abnormalities in C. vulgaris spermatids, including nuclear envelope invagination/fragmentation, disturbed chromatin condensation, dilated ER and autolytic vacuoles, and fragmented microtubular manchette, while flagella remain largely correctly formed[4].
Propyzamide (20 μM; 24-72 h) inhibits Vigna radiata seedling root elongation by approximately 20-25%[5].
Propyzamide (20 μM; 24-72 h) impairs lateral root development and causes root tip thickening in Vigna radiata seedlings[5]. In Vivo:Propyzamide (100 mg kg−1; gavage; 7 days) worsens anti-CD3-induced enteritis and T cell-driven small intestinal inflammation in mice[2].
Propyzamide (100 mg kg−1; intraperitoneally for 3 days and/or oral gavage) does not initiate intestinal inflammation or alter baseline intestinal immune populations in healthy mice[2].
Propyzamide (100 mg kg−1; intraperitoneally for 3 days until TNBS presensitization; then oral gavage for 6 consecutive days until TNBS rectal challenge) worsens TNBS-induced colitis in mice by amplifying pro-inflammatory AHR-NF-κB-C/EBPβ signalling[2].
Propyzamide (0.2-20 μM; in E3 medium; 24-72 h) amplifies TNBS-induced intestinal inflammation in zebrafish without initiating inflammation in naive larvae[2].

Your information is safe with us.